China Medical System Holdings Limited
Research China Medical System Holdings Limited (2M7C) on Bullrun: market cap EUR 3.02B, P/E 15.5, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2M7C
- ExchangeF
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 3.02B
- P/E15.5
- Dividend yield1.4%
- Financial periodFY2025
- RevenueCNY 8.21B
- Revenue growth9.9%
- Net incomeCNY 1.49B
- Free cash flowCNY 244.01M
- Gross margin71.5%
Valuation Snapshot
latest market cap is EUR 3.02B; P/E is 15.5; dividend yield is 1.4%.
Peer valuation comparison
Latest P/E is 15.5x versus a Healthcare sector median of 24.46x (36.6% below).
Latest dividend yield is 1.4% versus a Healthcare sector median of 2.11% (33.6% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 8.21B | CNY 1.49B | CNY 244.01M | 71.5% | 0.62 | CNY 2.70B | CNY 690.08M | CNY 17.40B |
| FY2024 | CNY 7.47B | CNY 1.62B | CNY 812.64M | 72.6% | 0.67 | CNY 3.71B | CNY 860.74M | CNY 16.31B |
| FY2023 | CNY 8.01B | CNY 2.40B | CNY 2.18B | 76.2% | 0.98 | CNY 4.31B | CNY 1.30B | CNY 15.52B |
| FY2022 | CNY 9.15B | CNY 3.26B | CNY 3.03B | 76.9% | 1.33 | CNY 4.38B | CNY 1.81B | CNY 14.59B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 3.02B | 15.5 | 3.0% | 0.04 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.04 EUR, yield 1.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.03 CNY |
| FY2024 | 0.03 CNY |
| FY2023 | 0.07 CNY |
| FY2022 | 0.07 CNY |
About China Medical System Holdings Limited
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China Medical System Holdings Limited's market cap?
China Medical System Holdings Limited's market capitalization is EUR 3.02B.
What is China Medical System Holdings Limited's P/E ratio?
China Medical System Holdings Limited's price-to-earnings (P/E) ratio is 15.5.
Does China Medical System Holdings Limited pay a dividend?
China Medical System Holdings Limited has a dividend yield of 1.4%.
What does China Medical System Holdings Limited do?
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate depression.